{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:58:25Z","timestamp":1789664305382,"version":"4.0.1"},"reference-count":97,"publisher":"Informa UK Limited","issue":"18","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.1080\/14656566.2025.2604681","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:53:46Z","timestamp":1765706026000},"page":"2013-2025","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Current pharmacological management, treatment challenges, and potential future treatment options for fibromyalgia syndrome"],"prefix":"10.1080","volume":"26","author":[{"given":"Georgina","family":"Lum","sequence":"first","affiliation":[{"name":"Southend University Hospital","place":["Essex, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Das","sequence":"additional","affiliation":[{"name":"Torbay and South Devon Foundation Trust","place":["Torquay, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Broomfield Hospital","place":["Broomfield, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Haider","family":"Tahir","sequence":"additional","affiliation":[{"name":"GKT School of Medicine","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hutchins","sequence":"additional","affiliation":[{"name":"University Hospitals Plymouth NHS Trust","place":["Plymouth, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Tahir","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust","place":["London, UK"]},{"name":"University College London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.03.003"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21896"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20042"},{"issue":"3","key":"e_1_3_5_5_1","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase iii trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease PJ","year":"2008","unstructured":"Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase iii trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35(3):502\u2013514.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_6_1","first-page":"91","article-title":"A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia","volume":"1","author":"Chappell AS","year":"2009","unstructured":"Chappell AS, Bradley LA, Wiltse C, et al. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med [Internet]. 2009;1:91\u2013102. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2840539\/","journal-title":"Int J Gen Med"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae707"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.032"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.49.3.235"},{"issue":"2","key":"e_1_3_5_10_1","first-page":"364","article-title":"Functional imaging of pain in patients with primary fibromyalgia","volume":"31","author":"Cook DB","year":"2004","unstructured":"Cook DB, Lange G, Ciccone DS, et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol. 2004;31(2):364\u2013378.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27497"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-32"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.014"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3136"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24849"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-007-0216-2"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000017"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33339"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2849-07.2007"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350509"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08m00680"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37842"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05623.x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918819944","article-title":"Fibromyalgia: genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers","volume":"15","author":"D\u2019Agnelli S","year":"2019","unstructured":"D\u2019Agnelli S, Arendt-Nielsen L, Gerra MC, et al. Fibromyalgia: genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Mol Pain [Internet]. 2019;15. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30486733\/","journal-title":"Mol Pain"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/pq0qp6"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06407-5"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928945"},{"key":"e_1_3_5_28_1","unstructured":"Pregabalin. Uses interactions mechanism of action | DrugBank online [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00230"},{"key":"e_1_3_5_29_1","unstructured":"Pregabalin | Drugs | BNF | NICE [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/pregabalin\/"},{"issue":"9","key":"e_1_3_5_30_1","first-page":"CD011790","article-title":"Pregabalin for pain in fibromyalgia in adults","volume":"2016","author":"Derry S","year":"2016","unstructured":"Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev [Internet]. 2016;2016(9):CD011790. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6457745\/","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_31_1","unstructured":"Gabapentin: uses interactions mechanism of action | DrugBank online [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00996"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22457"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12319"},{"issue":"1","key":"e_1_3_5_34_1","first-page":"CD012188","article-title":"Gabapentin for fibromyalgia pain in adults","volume":"2017","author":"Cooper TE","year":"2017","unstructured":"Cooper TE, Derry S, Wiffen PJ, et al. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev [Internet]. 2017;2017(1):CD012188. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6465053\/","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_35_1","unstructured":"Duloxetine | Drugs | BNF | NICE [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/duloxetine\/"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08m00680"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub2"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000558"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-03995-z"},{"key":"e_1_3_5_40_1","unstructured":"Duloxetine: uses interactions mechanism of action | DrugBank online [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00476"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S43395"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25532"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12216"},{"issue":"7","key":"e_1_3_5_44_1","first-page":"CD011824","article-title":"Amitriptyline for fibromyalgia in adults","volume":"2015","author":"Moore RA","year":"2015","unstructured":"Moore RA, Derry S, Aldington D, et al. Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev [Internet]. 2015;2015(7):CD011824. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6485478\/","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_45_1","unstructured":"Amitriptyline hydrochloride | Drugs | BNF | NICE [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/amitriptyline-hydrochloride\/"},{"key":"e_1_3_5_46_1","unstructured":"Amitriptyline: uses interactions mechanism of action DrugBank online [Internet]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00321"},{"key":"e_1_3_5_47_1","unstructured":"Amitriptyline prescribing information neuropathic pain - drug treatment CKS nice Available from: https:\/\/cks.nice.org.uk\/topics\/neuropathic-pain-drug-treatment\/prescribing-information\/amitriptyline\/"},{"key":"e_1_3_5_48_1","unstructured":"Cyclobenzaprine: uses interactions mechanism of action | DrugBank online [Internet]. [cited 2025 Oct 13]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00924"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20076"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.002"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2012.00234.x"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00441.x"},{"issue":"6","key":"e_1_3_5_53_1","first-page":"1323","article-title":"Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study","volume":"41","author":"Salaffi F","year":"2023","unstructured":"Salaffi F, Farah S, Sarzi-Puttini P, et al. Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study. Clin Exp Rheumatol [Internet]. 2023;41(6):1323\u20131331. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37378482\/","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"e_1_3_5_54_1","first-page":"CD012708","article-title":"Mirtazapine for fibromyalgia in adults","volume":"2018","author":"Welsch P","year":"2018","unstructured":"Welsch P, Bernardy K, Derry S, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev [Internet]. 2018;2018(8):CD012708. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6513659\/","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-204"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-95"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31829057ae"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1363659"},{"issue":"7","key":"e_1_3_5_59_1","article-title":"Predictors of treatment response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia","volume":"133","author":"Krupa AJ","year":"2023","unstructured":"Krupa AJ, Korkosz M, Gorostowicz A, et al. Predictors of treatment response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia. Pol Arch Intern Med [Internet]. 2023;133(7\u20138). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36799096\/","journal-title":"Pol Arch Intern Med"},{"key":"e_1_3_5_60_1","volume-title":"Guideline for the management of fibromyalgia syndrome pain in adults and children","author":"Buckhardt C","year":"2005","unstructured":"Buckhardt C, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. New York: Georg Thieme Verlag KG Stuttgart; 2005."},{"issue":"6","key":"e_1_3_5_61_1","first-page":"603","article-title":"Fibromyalgia syndrome - updated s3 guidelines","volume":"151","author":"Dreher T","year":"2013","unstructured":"Dreher T, H\u00e4user W, Schiltenwolf M. Fibromyalgia syndrome - updated s3 guidelines. Z Orthop Unfall [Internet]. 2013;151(6):603\u2013609. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24347415\/","journal-title":"Z Orthop Unfall"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/918216"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209724"},{"issue":"1","key":"e_1_3_5_64_1","first-page":"303","article-title":"Biopsychosocial model\u2013the integrated approach to health and disease","volume":"33","author":"Havelka M","year":"2009","unstructured":"Havelka M, Lucanin JD, Lucanin D. Biopsychosocial model\u2013the integrated approach to health and disease. Coll Antropol. 2009;33(1):303\u2013310.","journal-title":"Coll Antropol"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090367"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-012-1167-z"},{"issue":"12","key":"e_1_3_5_67_1","first-page":"742","article-title":"Guidelines for the diagnosis and treatment of the fibromyalgia syndrome","volume":"152","author":"Ablin JN","year":"2013","unstructured":"Ablin JN, Amital H, Ehrenfeld M, et al. Guidelines for the diagnosis and treatment of the fibromyalgia syndrome. Harefuah. 2013;152(12):742\u20137, 750, 751.","journal-title":"Harefuah"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.02.003"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07422-w"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14293"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2022.11.010"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzab200"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.2196\/42090"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111167"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062322"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2022.05.006"},{"issue":"7","key":"e_1_3_5_77_1","first-page":"CD011694","article-title":"Cannabinoids for fibromyalgia","volume":"2016","author":"Walitt B","year":"2016","unstructured":"Walitt B, Klose P, Fitzcharles MA, et al. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev [Internet]. 2016;2016(7):CD011694. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6457965\/","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_78_1","unstructured":"Recommendations | cannabis-based medicinal products | guidance | nice [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng144\/chapter\/Recommendations#chronic-pain"},{"key":"e_1_3_5_79_1","unstructured":"Nabilone 1mg capsule - summary of product characteristics (SmPC) - (emc) | 12767 [Internet]. [cited 2025 Oct 26]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/12767\/smpc#gref"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1500312"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200418"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S127288"},{"key":"e_1_3_5_83_1","unstructured":"Naltrexone hydrochloride | Drugs | BNF | NICE [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/naltrexone-hydrochloride\/"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S395457"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2009.01.052"},{"key":"e_1_3_5_86_1","unstructured":"Table 1 FDA-approved drugs for the treatment of fibromyalgia. 2015."},{"key":"e_1_3_5_87_1","unstructured":"Overview | Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain | Guidance | Nice [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng193"},{"key":"e_1_3_5_88_1","article-title":"A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center","volume":"10","author":"Rivera FA","year":"2024","unstructured":"Rivera FA, Munipalli B, Allman ME, et al. A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Front Med (Lausanne) [Internet]. 2024;10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38288305\/","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_5_89_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00307","article-title":"Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis","volume":"8","author":"Riediger C","year":"2017","unstructured":"Riediger C, Schuster T, Barlinn K, et al. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol [Internet]. 2017;8(Jul). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28769859\/","journal-title":"Front Neurol"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.2147\/jpr.s12160355"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25142"},{"key":"e_1_3_5_92_1","unstructured":"New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/www.accessnewswire.com\/newsroom\/en\/healthcare-and-pharmaceutical\/new-drug-study-shows-improving-sleep-quality-can-relieve-fibromyalgia-836263"},{"key":"e_1_3_5_93_1","unstructured":"FDA accepts new drug application for cyclobenzaprine HCl in management of fibromyalgia | pharmacy times [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/www.pharmacytimes.com\/view\/fda-accepts-new-drug-application-for-cyclobenzaprine-hcl-in-management-of-fibromyalgia"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.01.164"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34390"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00909-7"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030380"},{"key":"e_1_3_5_98_1","unstructured":"A study to analyze predictive pharmacogenomics in fibromyalgia - mayo clinic [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/www.mayo.edu\/research\/clinical-trials\/cls-20463728"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2604681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:11:50Z","timestamp":1770271910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2604681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":97,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,12,12]]}},"alternative-id":["10.1080\/14656566.2025.2604681"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2604681","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}